Rating Change
Barclays analysts reiterated a Equal-Weight rating on CME Group Inc. (NASDAQ:CME) on July 09, 2026.
reiterateNASDAQ:CME
Barclays Reiterates Equal-Weight Rating on CME Group Inc. (CME)
Rating Change Barclays analysts reiterated a Equal-Weight rating on CME Group Inc. (NASDAQ:CME) on July 09, 2026. Market Context CME Group Inc.
Market Context
CME Group Inc. operates in the Financial Services sector. The stock currently trades at $239.71 with a market capitalization of $98.2B. The stock has declined 10.4% over the past 52 weeks.
Analyst coverage from Barclays provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for CME Group Inc..
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for CME Group Inc.
Among the 10 most recent ratings: 6 Buy, 4 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Jul 09, 2026 | Barclays | Equal-Weight | N/A |
| Jul 06, 2026 | UBS | Neutral | N/A |
| Jul 02, 2026 | Raymond James | Outperform | N/A |
| Jun 18, 2026 | Keefe, Bruyette & Woods | Outperform | N/A |
| Jun 11, 2026 | Rothschild & Co | Buy | N/A |
Related Tools: Analyst Ratings Dashboard | View CME Stock Page
Frequently Asked Questions
What does a Equal-Weight rating mean for CME?
A Equal-Weight rating from Barclays reflects the analyst's outlook on CME Group Inc. (NASDAQ:CME). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the CME forecast page.
